Barts Life Sciences is excited to announce that we are recruiting for our third digital fellow post for our pioneering AI and machine learning programme CAP-AI. More information and how to apply can be found here: https://www.jobs.nhs.uk/xi/vacancy/916429449
Less than one-third of COVID-19 clinical trials are led by women, which is half the proportion observed in non-COVID-19 trials, according to research led by Queen Mary University of London, University of St Andrews, Brigham and Women’s Hospital and Harvard Medical School. The study suggests that gender disparities during the pandemic may signify not only a lack of women’s leadership...
Research from Queen Mary University of London has concluded that there is convincing evidence that type 2 diabetes is associated with an increased risk of Parkinson’s disease. 21 per cent increased risk of developing Parkinson’s. However, because Parkinson’s only affects around 1-2 per cent of people over the age of 60, people with type 2 diabetes still have a very...
People with unhealthy heart structures and poorer functioning hearts have a significantly higher risk of being diagnosed with COVID-19 infection, according to research by Queen Mary University of London, in collaboration with the Medical Research Council Lifecourse Epidemiology Unit (The University of Southampton). The researchers made use of the comprehensive and internationally unique UK Biobank database, which includes health and...
Pleased to announce Barts Life Sciences are recruiting for our second digital fellow post for CAP-AI, our pioneering research programme, aiming to place healthcare in East London at the forefront of the AI and technology revolution. More information and how to apply can be found here: http://jobs.bartshealth.nhs.uk/job/v3008688
Barts Life Sciences is delighted to announce that we are recruiting for digital fellows for our next cohort of artificial intelligence and machine learning projects, CAP-AI. Details and how to apply can be found here: https://www.jobs.nhs.uk/xi/vacancy/916408493
A new type of drug that helps target chemotherapy directly to cancer cells has been found to significantly increase survival of patients with the most common form of bladder cancer, according to results from a phase III clinical trial led in the UK by Queen Mary University of London and Barts Health NHS Trust. The results are published in the New...
Researchers from Barts Cancer Institute (BCI), Queen Mary University of London, have released a web-based tool called SNPnexus COVID (https://www.snp-nexus.org/v4/covid/) to streamline the analysis of host genetic sequencing data and allow for the identification and prioritisation of genetic variants that may impact an individual’s susceptibility to and the severity of COVID-19 infection. Since the emergence of the COVID-19 pandemic, global initiatives to...
This week, Barts Health NHS Trust reached a significant milestone in the fight against Covid-19. Since the pandemic started, the Trust has recruited more than 10,000 participants across 34 different Covid-19 studies, including 15 National Institute for Health Research ‘Urgent Public Health’ studies. This major contribution to the national effort against the virus has been achieved in the midst of...
New research suggests that a higher dietary intake of long chain omega-3 fatty acids in childhood may reduce the risk of developing subsequent asthma, but only in children carrying a common gene variant. The study, led by Queen Mary University of London, is in collaboration with the University of Bristol and University of Southampton, UK, and Karolinska Institutet, Sweden. In...
Accessibility options
Translate the page
